Related Experiment Video
Updated: Jun 26, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Homocysteine modulates sodium channel currents in human atrial myocytes
Benzhi Cai1, Luchen Shan, Dongmei Gong
1Department of Pharmacology, Harbin Medical University, Baojian Road 157, Harbin 150081, PR China.
Insights
High homocysteine levels in the blood disrupt heart cell sodium channels, increasing the risk of arrhythmias and ischemia. This study reveals how homocysteine affects these critical cardiac ion channels.
Area of Science:
- Cardiology
- Molecular Biology
- Electrophysiology
Background:
- Hyperhomocysteinemia is a suspected risk factor for cardiac arrhythmias and ischemia.
- The precise cellular mechanisms of homocysteine's cardiac toxicity are not fully understood.
- Aberrant sodium channel function is implicated in cardiac arrhythmias and ischemic injury.
Purpose of the Study:
- To investigate the toxic effects of homocysteine on cardiac sodium currents in human atrial cells.
- To elucidate the cellular mechanisms linking hyperhomocysteinemia to cardiac dysfunction.
Main Methods:
- Human atrial myocytes were isolated using enzymatic dissociation.
- Whole-cell patch clamp technique was used to record sodium currents and membrane potential.
- Experiments were conducted with and without varying concentrations of homocysteine.
Main Results:
- Pathological homocysteine concentrations significantly increased sodium currents and depolarized resting membrane potential.
- Homocysteine shortened time constants for sodium current activation and inactivation.
- Elevated homocysteine shifted the inactivation curve positively and accelerated recovery from inactivation, without affecting activation.
Conclusions:
- Increased homocysteine levels induce abnormalities in human atrial cell sodium currents.
- These alterations involve slowed inactivation and promoted recovery of sodium channels.
- Findings provide insight into the mechanisms of hyperhomocysteinemia-associated cardiac arrhythmias and ischemia.
Abstract:
Hyperhomocysteinemia has been proposed as an important risk factor for cardiac arrhythmias and ischemia worldwide. However, the cellular mechanism underlying toxic effects of homocysteine on hearts remains conjectural. It is well known that aberrant sodium channels can promote the development of cardiac arrhythmias and ischemic injury. So the present study was to investigate toxic effects of homocysteine on sodium currents recorded in human atrial cells. Human atrial myocytes were acutely enzymatically isolated and the whole-cell patch clamp technique was employed to record sodium currents and membrane potential in human atrial cells in the absence and presence of homocysteine. We found that in human atrial myocytes, sodium currents were significantly increased by pathological concentration of homocysteine with the maximum activation potential shifted toward the positive potential. However, physiological concentration of homocysteine did not have any effects on sodium currents. The time constants for time-dependent activation (tau(act)) and inactivation (tau(inact)) of sodium currents were both markedly shortened by elevated homocysteine levels. The further channel kinetic data showed that elevated homocysteine levels shifted the inactivation curve towards positive potential and accelerated the recovery from inactivation of sodium channel, but did not affect the activation of sodium channel. Additionally, the resting membrane potential of human atrial myocytes was obviously depolarized by elevated homocysteine levels in the current clamp model. Taken together, the data presented in this study first revealed that increased homocysteine levels caused the abnormality of sodium currents in human atrial cells by slowing the inactivation and promote the recovery of sodium channels, which provides a better understanding of hyperhomocysteinemia associated cardiac arrhythmias and ischemia.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Mechanism of Cardiac Arrhythmias
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
